A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity
Clinical trial NCT07478822 · RECRUITING
Trial details
- NCT number
- NCT07478822
- Sponsor
- Chongqing Claruvis Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-27
- Primary completion
- 2027-06-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.